🩺 iRemedy » $52M revenue in 2022

This campaign is closing soon!   iRemedy Closing Soon   ~/AAQRxQA~/RgRmpTceP0S7aHR0cHM6Ly9yZXB1YmxpYy5jb20vaXJlbWVkeT91dG1fc291cmNlPXJlcHVibGljLmNvJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW9mZmVyaW5ncyUyRmxhdW5jaF9hbm5vdW5jZW1lbnRfbWFpbGVyLm9mZmVyaW5nX2xhdW5jaGVkJnV0bV9jb250ZW50PWlyZW1lZHlfYWxsX2lyZW1lZHkmdXRtX3Rlcm09aXJlbWVkeVcDc3BjQgpkth6ywmTcXBQpUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~   iRemedy is using AI to improve the medical supply chain. They are creating a large procurement marketplace for medical supplies, which aims to help doctors, hospitals and healthcare providers get lifesaving supplies for their patients faster and more affordably. Their campaign has raised $94k+ and is closing soon. Highlights: - Offers a comprehensive solution for healthcare providers, simplifying medical supply procurement and management processes. - Provides an extensive product catalog, real-time inventory tracking, and convenient ordering options on an easy-to-use platform. - Empowers healthcare professionals to streamline their supply chain, minimize costs, and enhance patient care. - Leverages cutting-edge technology and industry expertise to provide supplies for their patients in a fast and cost-effective manner. Success so far: iRemedy’s patent protected AI-driven medical supply marketplace garnered $52M revenue in 2022 alone. Their technology, created by former Amazon Technology Vice President, boasts over 10,000 customers and 500,000 products and an executive team with numerous patents and successful exits. ~/AAQRxQA~/RgRmpTceP0S7aHR0cHM6Ly9yZXB1YmxpYy5jb20vaXJlbWVkeT91dG1fc291cmNlPXJlcHVibGljLmNvJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW9mZmVyaW5ncyUyRmxhdW5jaF9hbm5vdW5jZW1lbnRfbWFpbGVyLm9mZmVyaW5nX2xhdW5jaGVkJnV0bV9jb250ZW50PWlyZW1lZHlfYWxsX2lyZW1lZHkmdXRtX3Rlcm09aXJlbWVkeVcDc3BjQgpkth6ywmTcXBQpUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~ [View iRemedy on Republic](~/AAQRxQA~/RgRmpTceP0S7aHR0cHM6Ly9yZXB1YmxpYy5jb20vaXJlbWVkeT91dG1fc291cmNlPXJlcHVibGljLmNvJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW9mZmVyaW5ncyUyRmxhdW5jaF9hbm5vdW5jZW1lbnRfbWFpbGVyLm9mZmVyaW5nX2xhdW5jaGVkJnV0bV9jb250ZW50PWlyZW1lZHlfYWxsX2lyZW1lZHkmdXRtX3Rlcm09aXJlbWVkeVcDc3BjQgpkth6ywmTcXBQpUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~)   [Form CRS: Client Relationship Summary](~/AAQRxQA~/RgRmpTceP0QyaHR0cHM6Ly9maWxlcy5icm9rZXJjaGVjay5maW5yYS5vcmcvY3JzXzI5MTM4Ny5wZGZXA3NwY0IKZLYessJk3FwUKVIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO) Highlights are derived, and based entirely upon the Issuer’s representations. Prior results do not guarantee future success. Images provided by the issuer. Investments in private companies are particularly risky and may result in total loss of invested capital. [Form CRS: Client Relationship Summary.](~/AAQRxQA~/RgRmpTceP0QyaHR0cHM6Ly9maWxlcy5icm9rZXJjaGVjay5maW5yYS5vcmcvY3JzXzI5MTM4Ny5wZGZXA3NwY0IKZLYessJk3FwUKVIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO) An offering statement relating to The iRemedy Healthcare Companies, Inc.’s Common Stock has been filed with the Securities and Exchange Commission and became qualified on February 13, 2023. Prior to making any investment in The iRemedy Healthcare Companies, Inc.’s Common Stock, you should review a copy of the offering circular or contact The iRemedy Healthcare Companies, Inc. by phone at (407) 395-4283. No offer to sell any securities, and no solicitation of an offer to buy any securities, is being made in any jurisdiction in which such offer, sale, or solicitation would not be permitted by applicable law. [Risks Related to this Offering](~/AAQRxQA~/RgRmpTceP0RbaHR0cHM6Ly93d3cuc2VjLmdvdi9BcmNoaXZlcy9lZGdhci9kYXRhLzE2OTEyNDkvMDAwMTkwMzU5NjIzMDAwMTMwL2lyZW1lZHlfMjUzZzEuaHRtI2FfMDAwNFcDc3BjQgpkth6ywmTcXBQpUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~) This Reg A+ offering is made available through OpenDeal Broker LLC. This brief should not be construed as investment advice. Always consult with trusted professional advisors before making investments. Private investments are inherently illiquid and may result in total loss. Not [FDIC](~/AAQRxQA~/RgRmpTceP0QVaHR0cHM6Ly93d3cuZmRpYy5nb3YvVwNzcGNCCmS2HrLCZNxcFClSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~) or [SIPC](~/AAQRxQA~/RgRmpTceP0QVaHR0cHM6Ly93d3cuc2lwYy5vcmcvVwNzcGNCCmS2HrLCZNxcFClSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~) insured. Disclaimer: This email does not constitute an agreement to conduct transactions by electronic means and does not create any legally binding contract or enforceable obligation in the absence of a fully signed written contract. OpenDeal Broker LLC (CRD 291387) is a registered broker-dealer and member of FINRA and SiPC ([BrokerCheck website](~/AAQRxQA~/RgRmpTceP0QxaHR0cHM6Ly9icm9rZXJjaGVjay5maW5yYS5vcmcvZmlybS9zdW1tYXJ5LzI5MTM4N1cDc3BjQgpkth6ywmTcXBQpUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~)). Investment opportunities are not issued or guaranteed by OpenDeal Broker. Neither the Securities and Exchange Commission nor any federal or state securities regulator has recommended or approved any investment opportunity or the accuracy or completeness of any information or materials provided herein. OpenDeal Broker makes no representations or warranties as to the accuracy of the information herein, and we accept no liability for the same. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal, and financial advisers. [Terms of Use](~/AAQRxQA~/RgRmpTceP0QaaHR0cHM6Ly9yZXB1YmxpYy5jb20vdGVybXNXA3NwY0IKZLYessJk3FwUKVIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO), [Privacy Policy](~/AAQRxQA~/RgRmpTceP0QcaHR0cHM6Ly9yZXB1YmxpYy5jb20vcHJpdmFjeVcDc3BjQgpkth6ywmTcXBQpUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~), [Business Continuity Plan](~/AAQRxQA~/RgRmpTceP0Q_aHR0cHM6Ly9yZXB1YmxpYy5jby9jYXBpdGFsX3IvZG93bmxvYWQvYnVzaW5lc3NfY29udGludWl0eV9wbGFuVwNzcGNCCmS2HrLCZNxcFClSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~), [Additional Risk Disclosures](~/AAQRxQA~/RgRmpTceP0Q2aHR0cHM6Ly9yZXB1YmxpYy5jby9jYXBpdGFsX3IvZG93bmxvYWQvYWRkaXRpb25hbF9yaXNrVwNzcGNCCmS2HrLCZNxcFClSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~). Adjust your email preferences [here](~/AAQRxQA~/RgRmpTceP0QraHR0cHM6Ly9yZXB1YmxpYy5jb20vc2V0dGluZ3Mvbm90aWZpY2F0aW9uc1cDc3BjQgpkth6ywmTcXBQpUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~). [Unsubscribe from Launch emails](~/AAQRxQA~/RgRmpTceP0RJaHR0cHM6Ly9yZXB1YmxpYy5jby9lbWFpbHMvdW5zdWJzY3JpYmU_Y2F0ZWdvcnk9b2ZmZXJpbmdzJmZyZXF1ZW5jeT1uZXZlclcDc3BjQgpkth6ywmTcXBQpUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~) 149 E 23rd St #2001, New York, NY 10010 [Unsubscribe from all emails](~/AAQRxQA~/RgRmpTceP4TOAWh0dHBzOi8vMDUuZW1haWxpbmJvdW5kcHJvY2Vzc2luZy5jb20vZW5jX3VzZXIvdW5zdWJzY3JpYmU_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~) This email was sent by Republic. Crowdfunding investments can result in total loss, and may be impossible to resell. Read about risks. Republic Core LLC ("Core") provides technology and support services to OpenDeal Inc. and its affiliates (collectively, the "Republic Ecosystem"). Republic Note holders and as well as users of the site and services maintained by the Republic Ecosystem, regardless of and their activities on or relating to the Republic Ecosystem, are subject to the applicable terms of service, in their entirety. Core cannot give investment advice, analysis or recommendations with respect to any securities, and is not a registered broker-dealer, funding portal or investment adviser. Securities offerings displayed by Core may be facilitated by its affiliates in the Republic Ecosystem, OpenDeal Portal LLC d/b/a Republic, or OpenDeal Broker LLC d/b/a The CapitalR, Republic Capital Adviser LLC, Republic Deal Room Advisor LLC, Fig Publishing, Inc. or by a third-party issuer. This email is intended only for accredited investors with a pre-existing relationship with the Republic Ecosystem. Please notify the sender immediately if you have received this email by mistake, then delete it. Private investments are risky and illiquid, never invest more than you can afford to lose, consult with your trusted advisors and do your own diligence before investing. This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed; they do not constitute legal or investment advice. Please notify the sender immediately if you have received this e-mail by mistake, then delete it. No longer interested in new offering launch emails? Adjust your [notification settings](~/AAQRxQA~/RgRmpTceP0QraHR0cHM6Ly9yZXB1YmxpYy5jb20vc2V0dGluZ3Mvbm90aWZpY2F0aW9uc1cDc3BjQgpkth6ywmTcXBQpUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~). [Unsubscribe from all emails](~/AAQRxQA~/RgRmpTceP4TOAWh0dHBzOi8vMDUuZW1haWxpbmJvdW5kcHJvY2Vzc2luZy5jb20vZW5jX3VzZXIvdW5zdWJzY3JpYmU_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~) 149 E 23rd St #2001, New York, NY 10010